MEGA-R Stock Overview
Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Mega Lifesciences Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿40.50 |
| 52 Week High | ฿46.75 |
| 52 Week Low | ฿34.75 |
| Beta | 0.40 |
| 1 Month Change | -1.22% |
| 3 Month Change | 0% |
| 1 Year Change | 4.52% |
| 3 Year Change | 9.46% |
| 5 Year Change | 16.55% |
| Change since IPO | 90.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEGA-R | TH Pharmaceuticals | TH Market | |
|---|---|---|---|
| 7D | -0.6% | 0.1% | 0.004% |
| 1Y | 4.5% | 5.4% | -10.7% |
Return vs Industry: MEGA-R matched the TH Pharmaceuticals industry which returned 5.4% over the past year.
Return vs Market: MEGA-R exceeded the TH Market which returned -10.7% over the past year.
Price Volatility
| MEGA-R volatility | |
|---|---|
| MEGA-R Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in TH Market | 9.5% |
| 10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: MEGA-R has not had significant price volatility in the past 3 months.
Volatility Over Time: MEGA-R's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | n/a | Vivek Dhawan | www.megawecare.com |
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids’, men’s, and women’s care products.
Mega Lifesciences Public Company Limited Fundamentals Summary
| MEGA-R fundamental statistics | |
|---|---|
| Market cap | ฿35.31b |
| Earnings (TTM) | ฿2.02b |
| Revenue (TTM) | ฿15.72b |
17.5x
P/E Ratio2.2x
P/S RatioIs MEGA-R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEGA-R income statement (TTM) | |
|---|---|
| Revenue | ฿15.72b |
| Cost of Revenue | ฿8.47b |
| Gross Profit | ฿7.26b |
| Other Expenses | ฿5.24b |
| Earnings | ฿2.02b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 13, 2024
| Earnings per share (EPS) | 2.31 |
| Gross Margin | 46.15% |
| Net Profit Margin | 12.83% |
| Debt/Equity Ratio | 0.9% |
How did MEGA-R perform over the long term?
See historical performance and comparison